You’re invited to participate in the Targeted Oncology™ Community Case Forum™ (CCF) on Thursday, November 21 at The Westin Dallas Stonebriar Golf Resort & Spa. Targeted Oncology events are held in partnership with Healthcare Research & Analytics (HRA®) to gain market research insights into health care professionals' educational needs in their current practice setting. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend. HRA® offers compensation for consultative contributions during the event discussions, responses to polling questions, and completion of a post event survey.

CCF events are a special in-person only opportunity to connect with the local oncology community. Attendees will have the chance to network with peers before participating in one of three case-based discussions on multiple myeloma, lung cancer or prostate cancer. Physicians may select the topic that best matches their expertise and interest. Don’t delay; seating is limited for each moderated discussion.

Learn more and register!

Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

This live, virtual symposium will bring together a world-renowned expert in the management of breast cancer with a local community oncologist to discuss the role of next-generation selective estrogen receptor degraders (SERDs) in the treatment of hormone receptor–positive, HER2-negative (HR+/HER2-) breast cancer. In this program, the faculty will review recent clinical updates evaluating SERDs for metastatic HR+/HER2- breast cancer and discuss best practices to implement biomarker testing to guide treatment decisions. Case-based conversations will be included throughout the program to provide clinicians with the key takeaways of all the data. Participants will have the opportunity to reflect on how experts make clinical decisions with regards to initiating and sequencing therapy, as well as best practices in managing adverse events.
Learn More